Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Stucchi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|March 7, 2012
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort studyPiero Ruggenenti, Flavio Gaspari, Antonio Cannata, et al.
Frontiers in Genetics|August 21, 2019
Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 DiabetesElisabetta Valoti, Marina Noris, Annalisa Perna, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Diabetes|September 17, 2016
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled TrialPiero Ruggenenti, Manuela Abbate, Barbara Ruggiero, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Kidney International Reports|April 24, 2026
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous NephropathyMatias Trillini, Federica Casiraghi, Alessia Gennarini, et al.
Iscience|September 21, 2023
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by NeanderthalsMatteo Breno, Marina Noris, Nadia Rubis, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|March 7, 2012
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort studyPiero Ruggenenti, Flavio Gaspari, Antonio Cannata, et al.
Frontiers in Genetics|August 21, 2019
Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 DiabetesElisabetta Valoti, Marina Noris, Annalisa Perna, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Diabetes|September 17, 2016
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled TrialPiero Ruggenenti, Manuela Abbate, Barbara Ruggiero, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Kidney International Reports|April 24, 2026
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous NephropathyMatias Trillini, Federica Casiraghi, Alessia Gennarini, et al.
Iscience|September 21, 2023
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by NeanderthalsMatteo Breno, Marina Noris, Nadia Rubis, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 2